Skip to main content
  • emily-sickbert-bennett

    Sickbert-Bennett Discusses Mask Fit and Efficiency

    Emily Sickbert-Bennett, PhD, MS, associate professor of infectious diseases, in the division of infectious diseases, and director of the UNC Medical Center Infection Prevention, continues to share perspective and study learnings about mask filtration efficiencies. She contributed to the following news reports this month. How to avoid buying counterfeit N95 masks –  (USA Today) Na … Continued

  • CindyGay

    Gay Responds to Myths and Suspicions About COVID-19 Vaccine Efficacy and Safety

    Cindy Gay, MD, MPH, associate professor of medicine, division of infectious diseases and medical director of the UNC HIV Cure Center, responded to myths and suspicions about the efficacy and safety of the COVID-19 vaccine in the Charlotte Post. The report acknowledges that while ‘some people have died from the vaccine,’ a close look at the details of these deaths shows they are v … Continued

  • victor-garcia-martinez

    Antiviral Proves Effective at Preventing, Treating COVID-19 In Lab

    Using a novel in vivo research model containing human lung tissue, UNC School of Medicine scientists led by Victor Garcia, PhD, and Angela Wahl, PhD, demonstrated that the broad spectrum, experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection in human tissue in the lab. The number of new COVID-19 cases continues to rise in many p … Continued

  • UNC Health Talk: Should You Wear Two Masks?

    Emily Sickbert-Bennett, PhD, MS, associate professor in the division of infectious diseases, and director of UNC Medical Center Infection Prevention, explains new guidance about layering masks, released from the Centers for Disease Control and Prevention (CDC). Learn more in this UNC Health Talk article.  

  • mina-h-headshot-600x600-1.jpg

    Report from Malawi: Weathering a second wave—or tsunami—of COVID-19

    By Mina Hosseinipour, MD, MPH Officials announced the first confirmed case of COVID-19 in Malawi on April 2, 2020. At UNC Project Malawi, we’d been working for a month to carefully review and prepare for the virus. We established COVID preventive procedures and clinical management guidelines and planning for staff and staff relatives. We enhanced our oxygen supply through concent … Continued

  • victor-garcia-martinez

    Oral Drug Could Be Used to Prevent and Treat COVID-19 Infections

    The News & Observer reports that a drug tested at UNC-Chapel Hill could be used to both prevent and treat COVID-19 infections, according to new research published in Nature by senior author J. Victor Garcia, PhD. “This is something that is giving us hope that there might be an alternative that can be available in addition to the vaccine to help with the pandemic,” Garcia, pro … Continued

  • David Wohl, MD

    Wohl Talks With Media About COVID, Vaccine Distribution and FDA Approval of HIV Treatment

    David Wohl, MD, professor of medicine in the division of infectious diseases, continues to share perspective and guidance with North Carolina media. In February, he contributed to the following news stories about COVID-19. Demographic breakdown remains steady even as hospital numbers decline, figures show –  (CBS-17) UNC doctor debunks several myths surrounding the COVID-19 vacci … Continued

  • weber-860x574-1-600x400-1.jpeg

    Testing Asymptomatic Healthcare Personnel for COVID-19 Not Recommended

    Routine testing of asymptomatic healthcare personnel (HCP) in the absence of confirmed exposures to COVID-19 is not a recommended strategy for preventing transmission of SARS-CoV-2 causing the current global pandemic, according to a new review co-authored by David Weber, MD, MPH, professor of medicine in the division of infectious diseases and medical director of infection preven … Continued

  • MikeCohenNAMheadshotsJCL201.jpg

    Study: Antibody Treatment Can Help Prevent People From Contracting COVID

    WRAL.com reports that an antibody infusion therapy designed to help coronavirus patients recover faster may prevent people from getting the virus. The clinical trial conducted by UNC, the National Institutes of Health and pharmaceutical company Eli Lilly, in more than 100 nursing homes across the country, shows promising results, with the data suggesting that the antibodies can r … Continued

  • David Wohl, MD

    Smooth Sailing For COVID-19 Vaccine Recipients at UNC-Chapel Hill Clinic

    David Wohl, MD, professor of medicine in the division of infectious diseases, talked with CBS-17 about UNC Health’s biggest vaccine clinic, held last week at the Friday Center.  The article recognizes the goal to vaccinate 10,000 people in one week, including health care workers, long-term-care staff and residents, and adults 65 years and older, and identifies who is next in line … Continued